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LACK OF CORRELATION BETWEEN GOUT AND THE INCORPORATION
OF ISOTOPIC FORMATE INTO URIC ACID
Certain reports"u have indicated that patients with gout incorporate the
isotopic precursors of the purine ring into urinary uric acid to a greater
extent than do non-gouty individuals. The possibility of utilizing this dif-
ference as a diagnostic test for gout has been explored. Carbon-14 labeled
sodium formate was given orally or intravenously to 10 patients known to
have gout, to 3 with hyperuricemia but no gouty symptoms, and to 16 non-
gouty subjects without elevated serum uric acid levels. Three patients who
had received oral formate were also given intravenous doses after the
urinary uric acid specific radioactivity had become negligible. No correla-
tion between the incorporation of isotope into urinary uric acid and the
presence of gout or hyperuricemia was noted.
METHODS
For oral administration doses were prepared that contained 10ac. (0.6 mg.)
of sodium formate-C" mixed with 400 mg. of lactose. Enough labeled sodium formate
for several doses was dissolved in a small quantity of water, added to dry lactose, and,
after drying in a vacuum oven, the mixture was ground in a mortar and weighed into
gelatin capsules on an analytical balance. The specific radioactivities of the mixture
were found to be constant between capsules, and the radioactivity was shown to be
virtually all formate by specific oxidation with mercuric ion.' For intravenous adminis-
tration sodium formate-C" was dissolved in a vial of sterile physiological saline
to a concentration of 10c. (0.6 mg.) in 3 ml. and autoclaved.
For experiments with oral dosage hospital patients who had just voided were given
a capsule at 8:00 a.m. Breakfast was withheld until 10:00 a.m. and urine was col-
lected until 4:00 p.m. The intravenous experiments were identical except that the
dose contained no lactose.
After removal of a 5 ml. aliquot from the eight-hour urine specimen for uric acid
determination the bulk of the remaining uric acid was precipitated as ammonium
urate.' After the crude precipitate had settled it was concentrated by centrifugation,
converted to uric acid with 3 ml. of 6 N hydrochloric acid, and washed with 3 ml. of
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water. It was then dissolved in a minimal quantity of N lithium hydroxide. After
centrifuging to remove insoluble impurities, the supernatant was filtered by suction
through a 0.5 by 5 cm. column of a half and half mixture of cellulose and charcoal.
The column was poured on 2 cm. of pure cellulose to prevent the escape of charcoal
into the filtrate. Uric acid was finally precipitated by acidification of the filtrate with
glacial acetic acid. The centrifuge tube containing the sample was placed in boiling
water for five minutes to convert a very flocculent precipitate to granular crystals. The
product was twice recrystallized by solution in lithium hydroxide and precipitated with
acetic acid. The purified uric acid was washed twice each in water, alcohol, and ether,
and dried in a vacuum oven. The specific radioactivity of the recrystallized, material was
identical to that first precipitated with acetic acid. A high state of purity was confirmed
spectrophotometrically.
Determination of the specific radioactivity was performed by proportional gas
counting after sealed tube combustion.' Uric acid determinations of urine and some of
serum were performed by the photometric uricase method of Kalckar8 as modified by
Praetorius.' Prepared tubes of buffered uricase* were used for most determinations.
Serum levels were also performed by the hospital clinical chemistry laboratory with
the Folin colorimetric method.'0
The diagnosis of gout was established by history and the presence of arthritis
typical of gout. It was confirmed in all but one instance by at least one serum uric
acid level above 8 mg. per cent. The exception (A.C. Table 2) had a ten-year history
of attacks of acute arthritis typical of gout and relieved by colchicine. Two gout
patients had tophi. Three patients had elevated serum uric acid levels but no arthritis.
Two of these had nephrolithiasis and the highest serum uric acid of one (M.S., Table
1) was 7.8 mg.%o. Criteria for the absence of gout in the control series were: failure
to elicit a history of arthritis resembling gout. absence of physical signs, and serum
uric acid levels below 8 mg.
RESULTS
Table 1 gives the data on the patients who received oral doses and Table
2 gives the data on those getting labeled formate intravenously. The two
patients with hyperuricemia and the one with questionable hyperuricemia
and urate stone are listed with the gouts. The specific radioactivities of the
uric acid isolated from the oral dose group were considerably higher than
those in the intravenous group. Serum uric acid levels are given for each
patient. The values first listed for each patient in Table 1 are those obtained
from blood taken on the day of the study, and where the uricase method
was employed, the Folin result given on the same line was obtained on the
same serum. In general the uricase levels were slightly higher. The other
values (all Folin) were obtained on various other occasions during the
patients' hospitalizations. Uricase determinations were not performed on
the sera of most of the patients of Table 2 and those few that were done
*Determatube-U, Worthington Biochemical Corporation, Freehold, New Jersey.
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Volume 34, August 1961TABLE 2. INCORPORATION INTO URINARY URIC AcI OF ISOTOPIC FORMATE GIVEN
INTRAVENOUSLY
Uric acid Total excreted
Excretion specific radioactivity
Serum uric acid in 8 hrs. radioactivity in uric acid
Patient Diagnoses mg. % mg. cts/m/mg. cts
CONTROLS
W.M. Infectious 4.5, 4.8 335 57 19,100
mononucleosis
J.Z. Duodenal ulcer 6.3 354 40 14,200
J.D. Hemorrhagic cyst 4.4,3.9 272 51 13,900
of thyroid
E.C. Traumatic 3.7, 5.0, 4.2 194 48 9,310
myositis
M.G. Chronic lymphatic 3.7,5.0,4.5 182 33 6,000
leukemia 4.6, 5.2
A.Q. Contact dermatitis 6.2 236 25 5,900
M.T. Undiagnosed renal 6.3,6.0,4.2 264 20 5,280
disease, elevated 4.8,4.6
BUN
V.T. Duodenal ulcer 6.0,4.3,6.9 87 41 3,570
M.H. Hypertensive 3.8 160 21 3,360
cardiovascular
disease, cerebrovascular
accident
GOUTS
G.O. Gout 12.5, 7.1, 9.0 268 32 8,580
7.5,8.0,7.5,
6.8,6.8,8.5,
11.0, 11.3
G.C. Gout, diabetes 8.2, 7.0, 6.0 211 39 8,230
sarcoma 6.1,6.8, 6.3,
7.4
A.K. Gout, arteriosclerotic 9.0,6.1 147 51 7,500
and rheumatic heart
disease
F.F. Gout, tophi 7.0, 7.3, 4.6. 298 25.0 7,450
5.3,7.4,6.5,
10.5,6.5,7.0
F.L. Hyperuricemia, 11.0, 9.3, 9.3 - 18.8
senile cataract,
No arthritis
A.C. Gout, chronic 6.5, 4.7 240 18.2 4,370
cellulitis
J.F. Gout, cerebrovascular 12.5,5.8 - 11.0
accident
J.G. Gout, hypertensive 5.5, 9.2 268 6.85 1,840
cardiovascular
diseaseYALE JOURNAL OF BIOLOGY AND MEDICINE
are grouped with the results from the clinical chemistry laboratory. The
uric acid content of each eight-hour urine is listed in each table.
In the oral dose series five non-gouty subjects showed a higher specific
radioactivity of uric acid than any gouty subject, and the patient with the
lowest value had gout. There was a four-fold spread of values among the
non-gouty patients as well as among the gouty patients. When the total
25
A.C.
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20
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6 32 48 64 80 96
HOURS
FIG. 1. Specific radioactivity of urinary uric acid from two patients with gout who
received 10 luc. of formate-C" intravenously.
counts in excreted uric acid were computed, the three highest values fell
in the control group, and again the patient with the lowest value had gout.
The correlation between uric acid specific radioactivity and gout was
equally as poor in the patients who received the labeled formate by vein.
When the data were computed on the basis of total counts in excreted uric
acid, the correlation was no better. Again the patient with the lowest in-
corporation by either method of computation had gout. Because these
studies covered only an eight-hour period, urine from this patient (J. G.)
and one other (A. C.) was collected over a longer period. The results are
shown in Figure 1. In both patients the peak specific radioactivity occurred
36
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in the sample collected between 8 and 16 hours but in neither did it rise to
the level seen in the majority of the non-gouty control patients.
DISCUSSION
The work of Benedict et al.,1'2 who administered N'1 glycine, seemed to
indicate that at least some patients with gout incorporate greater quantities
of isotope into uric acid than do normal subjects. However, two of the four
gouty subjects studied could not be distinguished from the two normal
controls. Wyngaarden' postulated that the large chemical dose of glycine
used might have masked the difference in incorporation, and with tracer
doses of C' glycine he found a high correlation between the extent of in-
corporation and gout. Each of seven gouty patients (one of these with
asymptomatic hyperuricemia) incorporated more isotope into urinary uric
acid than did three control subjects. Spillman8 gave C4 formate to two
patients with gout and two normal controls. The gouty patients had a six-
fold greater peak specific radioactivity in the urinary uric acid than did the
controls. He also found, as had Wyngaarden, that the peak specific radio-
activity occurred much sooner in the patients with gout. These findings led
us to believe that a short-term collection of urine would be more useful
diagnostically than a longer time study with multiple samples. It would
certainly be more convenient.
A subsequent report by Wyngaarden" includes data on two gouty sub-
jects that did not incorporate more isotopic glycine than did the controls,
and an accompanying paper by Seegmiller et al."2 reported that two subjects
without gout had a higher degree of incorporation than previously reported
control subjects.
Other laboratories have reported similar studies which involved only one
or two patients with one control in each study. In both experiments with a
single gouty patient'8"4 the degree of incorporation was indistinguishable
from that of the control. In the study involving two gouty subjects? the
peak isotope content of uric acid in the control fell between those of the
gouty patients.
In all of the reports that we have seen, 26 gouty patients (including
asymptomatic hyperuricemia) and 14 control subjects have been studied.
Because different compounds and somewhat different techniques were
employed, it is difficult to reduce all data to a common basis for comparison.
However, only 14 of the gouty subjects incorporated significantly more
isotope than the control subjects of the same study.
Our study is in essential agreement with this composite picture except
that we found the highest incorporation in patients of the control group.
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When the data are considered in the light of information already available,
it appears that there is great variability in the extent of incorporation of
isotopic precursors into urinary uric acid in gouty as well as in non-gouty
subjects. It would appear that a very extensive study and careful statistical
analysis would be necessary if any significant difference between gouts and
normals were to be uncovered by this type of study.
It is beyond the scope of this paper to review the evidence that gout is
related to the overproduction of uric acid by a "shunt" mechanism,1 but
the results of isotopic studies have been given as the chief evidence to
support this hypothesis. If all the studies cited are considered, the evidence
in support of the overproduction theory seems weak indeed, and it is
possible that the results of individual studies that have favored the over-
production theory occurred only fortuitously. The view that the hy-
peruricemia of gout may be related to a defect in the renal excretion of
uric acid has been considerably strengthened by a report by Nugent and
Tyler."7 These workers pointed out that in earlier clearance studies serum
levels of uric acid were not at the same levels in the gouty patients and in
the controls. When they maintained elevated levels in the control subjects
by dietary supplementation with ribose nucleic acid, the uric acid clearance
rates were much higher in the non-gouty subjects than in those with the dis-
order. Latham and Rodnane8 have very recently confirmed these findings
by infusing lithium or sodium urate.
SUMMARY
Isotopically labeled formate was administered orally or intravenously to
patients with gout or asymptomatic hyperuricemia and to control patients.
Urinary uric acid was isolated from urine voided during the eight-hour
period following the dose. No correlation between the presence of the
disease and the specific radioactivity of the uric acid was found.
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